Paris, France · Founded 2019 · Privately Held (backing)
Developer of a drug discovery platform designed to discover new drugs for specific therapeutic targets. AQEMIA is based in Paris, France and was founded in 2019. Its last reported valuation was $244 million in Dec 2024. It has raised $69.5 million.
Last reported valuation
$243.6M
Oct 2026
Priced at
—
Total raised
$69.5M
Last round
—
Team — not yet on record
No current team members for AQEMIA are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AQEMIA with a free account
·The complete investor list: 12 names
·Watch AQEMIA: the Monday email on marks, rounds and moves
